NEWRON (EGFF)
One of 10,000+ projects Taiyo tracks in Italy.
Source: European Investment Bank (EIB)
Newron Pharmaceuticals S.p.A. is a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central nervous system. The company is operational and already has one drug on the market (Xadago). The investment programme consists of the discovery, pre-clinical and clinical development of a portfolio of assets, addressing different therapeutic areas focu
- Status
- Under Construction
- Sector
- Government
- Location
- Italy
- Updated
- 22 Jul 2026
- Source
- European Investment Bank (EIB)
ConstructChat
Ask ConstructChat about NEWRON (EGFF)
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
Sponsoring Agency |
Status
Original status | signed |
Taiyo status | Under Construction |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | Newron Pharmaceuticals S.p.A. is a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central nervous system. The company is operational and already has one drug on the market (Xadago). The investment programme consists of the discovery, pre-clinical and clinical development of a portfolio of assets, addressing different therapeutic areas focusing on underserved neurological conditions. The candidates are at various developmental stages. |
Original sector | Services |
Location
Country | Italy |
Source
Source | European Investment Bank (EIB) |
URL |
More Details
Record type | Project |
Sector | Government |
Article published date | 2025-07-28 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
